Thu, Sep 18, 2014, 1:27 PM EDT - U.S. Markets close in 2 hrs 33 mins

Recent

% | $
Quotes you view appear here for quick access.

Immune Pharmaceuticals, Inc. Message Board

  • ghosttraderg ghosttraderg Aug 2, 2012 5:40 PM Flag

    EpiCept to Report Second Quarter

    EpiCept to Report Second Quarter 2012 Operating and Financial Results on August 8, 2012

    TARRYTOWN, N.Y.--(BUSINESS WIRE)-- Regulatory News:

    EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that it will host a conference call to discuss second quarter 2012 operating and financial results on Wednesday, August 8, 2012 at 9:00 a.m. Eastern time. The call will follow the release of these financial results earlier in the day at 12:01 a.m. Eastern time.

    To participate in the live call and be able to participate in the question and answer session, please dial from the U.S. and Canada (877) 809-8594 or from international locations (706) 758-9407 (please reference access code 17527052) prior to the start of the conference. The conference call will also be broadcast live in listen-only mode on the Internet and may be accessed at www.epicept.com. The webcast will be archived for 90 days.

    A telephone replay of the call will be available for seven days by dialing from the U.S. and Canada (855) 859-2056 or from international locations (404) 537-3406 (please reference reservation number 17527052).

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I would guess the cash is the most interesting to look at.The BOD/management has done nothing to cut costs!

      Sorry kosar lille your EPCT position in Avanza kapitalförsökring will be a huge loss.

      What happened with "all-in"? You are all-over the stock market with your rear mirror trades!

      -14% well some pattern is constant!

 
IMNP
3.600.00(0.00%)12:34 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.